20 Stocks Moving in Wednesday's Pre-Market Session

Gainers

  • Galera Therapeutics, Inc. GRTX rose 17.7% to $3.18 in pre-market trading after BTIG upgraded the stock from Neutral to Buy and announced a $15 price target. Galera Therapeutics shares jumped around 96% on Tuesday after the company announced the primary endpoint met statistical significance in corrected topline efficacy data of Phase 3 ROMAN trial of avasopasem.
  • SeaChange International, Inc. SEAC rose 16.6% to $1.76 in pre-market trading after the company reported better-than-expected Q3 results.
  • CF Acquisition Corp. VI CFVI rose 11.5% to $12.55 in pre-market trading after Trump Media & Technology Group announced a partnership with Rumble. Rumble recently announced the execution of a definitive business combination agreement with CFVI.
  • Biofrontera Inc. BFRI rose 9.8% to $6.04 in pre-market trading after dipping more than 19% on Tuesday.
  • Inpixon INPX rose 8.9% to $0.73 in pre-market trading. Inpixon recently said its board has authorized review of strategic alternatives.
  • East Stone Acquisition Corporation ESSC rose 8.4% to $14.63 in pre-market trading after declining 26% on Tuesday.
  • Uxin Limited UXIN rose 8.3% to $1.82 in pre-market trading. Uxin reported second-quarter FY22 revenue growth of 353% year-on-year to RMB345.9 million ($53.7 million).
  • Mesoblast Limited MESO rose 8.2% to $4.51 in pre-market trading. Mesoblast shares dropped around 28% on Tuesday after the company was notified by Novartis that it has chosen to terminate the agreement with Mesoblast prior to closing.
  • Borr Drilling Limited BORR rose 7.7% to $1.65 in pre-market trading after declining over 4% on Tuesday..
  • Li-Cycle Holdings Corp. LICY rose 6% to $11.50 in pre-market trading. Li-Cycle recently announced plans to increase hub facility's input processing capacity by over 40%.
  • Tuniu Corporation TOUR rose 5.7% to $1.02 in pre-market trading.


Find out what's going on in today's market and bring any questions you have to Benzinga's PreMarket Prep.

Check out these big penny stock gainers and losers

Losers

  • Sidus Space, Inc. SIDU fell 14.1% to $10.47 in pre-market trading. Sidus Space shares jumped 144% on Tuesday after the company priced its IPO at $5 per share.
  • Alzamend Neuro, Inc. ALZN fell 10.1% to $2.77 in pre-market trading after jumping 28% on Tuesday.
  • Idera Pharmaceuticals, Inc. IDRA shares fell 9.8% to $0.7850 in pre-market trading.
  • Adagio Therapeutics, Inc. ADGI fell 9.2% to $6.59 in pre-market trading after Stifel downgraded the stock from Buy to Hold and lowered the price target from $50 to $9. Adagio Therapeutics shares dipped 79% on Tuesday after the company said based on the in vitro findings related to Omicron, it plans to pause patient recruitment in its Phase 2/3 COVID-19 treatment trial at clinical sites in South Africa.
  • MIND Technology, Inc. MIND shares fell 7.9% to $1.64 in pre-market trading. MIND Technology shares gained 30% on Tuesday after the company reported it entered into a Cooperative Research and Development Agreement with the United States Navy's Naval Surface Warfare Center, Panama City Division.
  • Legend Biotech Corporation LEGN shares fell 7.3% to $45.00 in pre-market trading after the company reported an offering of $300 million in ADSs.
  • BeiGene, Ltd. BGNE fell 6.6% to $260.00 in pre-market trading. BeiGene reported authorisation of BRUKINSA (zanubrutinib) from the UK’s MHRA for the treatment of adults with Waldenström’s Macroglobulinemia in Great Britain.
  • Livent Corporation LTHM fell 6.6% to $23.69 in pre-market trading. Goldman Sachs downgraded Livent from Neutral to Sell and announced a $23 price target.
  • Leslie's, Inc. LESL shares fell 5.6% to $20.33 in pre-market trading after the company reported an offering of 12.5 million shares of common stock via selling shareholders.
Market News and Data brought to you by Benzinga APIs
Comments
Loading...
Posted In: NewsPenny StocksSmall CapPre-Market OutlookMarketsMoversTrading IdeasPre-Market MoversTop Gainers
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!